logo of the vendor
Pharma Intelligence UK Ltd logo

Bringing Artificial Intelligence to End-to-End Quality Management Systems

thumbnail of content

As the use of AI becomes more widespread, drug and device developers are wondering how it can be leveraged to improve their processes. Pharma Ignite, in partnership with IQVIA Technologies, takes you inside the key considerations for using AI to augment and enhance QMS, with the aim of keeping developers in compliance and ensuring patient safety.


Learn more now about:


  • The state of QMS today
  • Necessary elements for an effective QMS
  • How AI can be used to streamline time-consuming QM tasks
  • Understanding what AI can – and cannot – do within a QMS
  • The role of humans in AI augmented systems
  • Overcoming the barriers to AI adoption to reap the rewards of improved quality operations


Download the Whitepaper

Opt In?

Please complete all required fields to access the content!

Explore similar content

ThermoFisher
Pharma Intelligence UK Ltd

Securing your samples: Strategies for safeguarding critical biological materials

To deliver these therapies to the patients who need them, their success hinges on effective storage and management to maintain integrity throughout their lifecycle. From early development to commercialization, safeguarding sensitive biological materials demands scalable storage solutions and meticulous risk mitigation strategies. Partnering with a CDMO specializing in ultracold storage and biorepository management is critical to preserving product integrity and ensuring continuity throughout every development stage. This webinar will explore how the right CDMO partner can streamline biological material storage, mitigate risks, and provide the scalability needed to support growth from clinical trials to commercial launch, empowering you to advance your pipeline with confidence. Participants will gain insight into:
Webinar Clinical Studies Pharmaceutical Research and Development
IQVIA Technologies
Pharma Intelligence UK Ltd

A New Era of Participant Payment Services

Financial burdens are cited as one of the main barriers to clinical trial recruitment and retention, with traditional methods proving unreliable, complicated and slow. For trial sites and sponsors, the administration burden can be overwhelming, especially on a global scale. Discover how IQVIA’s Participant Payment service is transforming the participant payment landscape, simplifying the process and driving clinical trial success, by offering:
Article Clinical Studies Pharmaceutical Research and Development
Novotech
Pharma Intelligence UK Ltd

From biomarkers to regulatory compliance, and the impact of AI/ML

The field of precision medicine is rapidly evolving, enabling the development of innovative therapies highly tailored to individuals’ genetic profiles - resulting in revolutionized treatments and improved patient outcomes. Discover expert insights on the current landscape of personalized medicine, including the opportunities and challenges, including:
Report Clinical Studies Pharmaceutical Research and Development